Latest News about LGVN
Recent news which mentions LGVN
   Does Bone Marrow Contain The Keys To Curing Alzheimer's? BioTech Announces Promising Results From Clinical Trial
   
  October 13, 2023
  Tickers 
   LGVN
  
  
  From Benzinga
 
   12 Health Care Stocks Moving In Thursday's Pre-Market Session
   
  
  
  October 12, 2023
  From Benzinga
 
   12 Health Care Stocks Moving In Monday's Intraday Session
   
  
  
  October 09, 2023
  From Benzinga
 
   12 Health Care Stocks Moving In Monday's Pre-Market Session
   
  
  
  October 09, 2023
  From Benzinga
 
   12 Health Care Stocks Moving In Friday's Pre-Market Session
   
  
  
  October 06, 2023
  From Benzinga
 
   12 Health Care Stocks Moving In Thursday's Intraday Session
   
  
  
  October 05, 2023
  From Benzinga
 
   Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
   
  
  
  October 05, 2023
  From Benzinga
 
   Longeveron stock jumps on Alzheimer’s trial results
   
  
  
  October 05, 2023
  From MarketWatch
 
   12 Health Care Stocks Moving In Friday's Pre-Market Session
   
  
  
  September 15, 2023
  From Benzinga
 
   Roth MKM Analyst Projects An Impressive Price Target Of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says "Low Valuation Undeserved"
   
  
  
  September 14, 2023
  From Benzinga
 
   Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market
   
  
  
  September 11, 2023
  From Benzinga
 
   Upcoming Phase 2 Data Expected For Longeveron's (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer's Sector – What To Look For
   
  
  
  September 06, 2023
  From Benzinga
 
   Why Lands' End Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
   
  
  
  August 31, 2023
  From Benzinga
 
   US Stocks Rise; Initial Jobless Claims Edge Lower
   
  
  
  August 31, 2023
  From Benzinga
 
   12 Health Care Stocks Moving In Thursday's Pre-Market Session
   
  
  
  August 31, 2023
  From Benzinga
 
   As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs
   
  
  
  August 29, 2023
  From Benzinga
 
   Earnings Scheduled For August 11, 2023
   
  
  
  August 11, 2023
  From Benzinga
 
   Longeveron – This Biotech Company Is Using The Body's Own Cells To Fight Age-Related Diseases
   
  August 07, 2023
  Tickers 
   LGVN
  
  
  From Benzinga
 From Benzinga
 
   Longeveron – Regenerative Medicine Developer Announces 100% Long Term Survival Rate For Children With HLHS
   
  July 11, 2023
  Tickers 
   LGVN
  
  
  From Benzinga
 From Benzinga
 Tickers 
   LGVN
  
  
  From InvestorPlace
 
   Earnings Scheduled For May 12, 2023
   
  
  
  May 12, 2023
  From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
